Jeonghyeon Kim Selected Research

Tretinoin (Retinoic Acid)

1/2023

UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stability.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeonghyeon Kim Research Topics

Disease

3	Neoplasms (Cancer) 01/2023 - 01/2019
2	Osteoporosis 11/2023 - 10/2020
2	Obesity 11/2023 - 09/2018
2	Fibrosis (Cirrhosis) 01/2022 - 12/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2023
1	Anemia 11/2022
1	Hyperplasia 01/2022
1	Inflammation (Inflammations) 01/2022
1	Asthma (Bronchial Asthma) 01/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 12/2021
1	Pneumonia (Pneumonitis) 12/2021
1	Breast Neoplasms (Breast Cancer) 12/2020
1	Metabolic Bone Diseases (Osteopenia) 10/2020
1	Genomic Instability 01/2020
1	Candidiasis (Moniliasis) 12/2012

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 10/2020 - 01/2020
1	Biomarkers (Surrogate Marker)IBA 11/2023
1	CholesterolIBA 08/2023
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2023
1	Estrogen ReceptorsIBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 11/2022
1	InterleukinsIBA 01/2022
1	Interleukin-13IBA 01/2022
1	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 01/2022
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2021
1	Protein Glutamine gamma Glutamyltransferase 2IBA 12/2021
1	Metalloproteases (Metalloproteinases)IBA 12/2021
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 12/2021
1	Maytansine (Maitansine)IBA 12/2020
1	Nucleotide AptamersIBA 12/2020
1	Parathyroid Hormone (Parathormone)IBA 10/2020
1	CalciumIBA 10/2020
1	Vitamin D FDA LinkGeneric 10/2020
1	VitaminsIBA 10/2020
1	UbiquitinIBA 01/2019
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 09/2018
1	ginsenoside ReIBA 12/2012

Therapy/Procedure

2	Therapeutics 01/2022 - 12/2020